These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

915 related articles for article (PubMed ID: 32483459)

  • 41. Disulfiram combined with copper inhibits metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma through the NF-κB and TGF-β pathways.
    Li Y; Wang LH; Zhang HT; Wang YT; Liu S; Zhou WL; Yuan XZ; Li TY; Wu CF; Yang JY
    J Cell Mol Med; 2018 Jan; 22(1):439-451. PubMed ID: 29148232
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The combination of disulfiram and copper for cancer treatment.
    Li H; Wang J; Wu C; Wang L; Chen ZS; Cui W
    Drug Discov Today; 2020 Jun; 25(6):1099-1108. PubMed ID: 32320854
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Polydopamine-Modified Copper Coordination Mesoporous Silica Nanoparticles Loaded with Disulfiram for Synergistic Chemo-Photothermal Therapy.
    Ling J; Cai Y; Feng H; Liu Z; Ouyang XK
    Pharmaceutics; 2024 Apr; 16(4):. PubMed ID: 38675173
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Engineering of a double targeting nanoplatform to elevate ROS generation and DSF anticancer activity.
    Li W; Huang H; Yao S; Zhao Y; Liu M; Liu X; Guo H
    J Mater Chem B; 2024 Jul; 12(29):7143-7152. PubMed ID: 38904428
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Disulfiram/copper markedly induced myeloma cell apoptosis through activation of JNK and intrinsic and extrinsic apoptosis pathways.
    Xu Y; Zhou Q; Feng X; Dai Y; Jiang Y; Jiang W; Liu X; Xing X; Wang Y; Ni Y; Zheng C
    Biomed Pharmacother; 2020 Jun; 126():110048. PubMed ID: 32145587
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Silk Fibroin-Modified Disulfiram/Zinc Oxide Nanocomposites for pH Triggered Release of Zn
    Zhao YZ; Lin MT; Lan QH; Zhai YY; Xu HL; Xiao J; Kou L; Yao Q
    Mol Pharm; 2020 Oct; 17(10):3857-3869. PubMed ID: 32833457
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Polydopamine-mediated bio-inspired synthesis of copper sulfide nanoparticles for T
    Xiong Y; Sun F; Zhang Y; Yang Z; Liu P; Zou Y; Yu Y; Tong F; Yi C; Yang S; Xu Z
    Colloids Surf B Biointerfaces; 2019 Jan; 173():607-615. PubMed ID: 30359959
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A tumor microenvironment-responsive core-shell tecto dendrimer nanoplatform for magnetic resonance imaging-guided and cuproptosis-promoted chemo-chemodynamic therapy.
    Ni C; Ouyang Z; Li G; Liu J; Cao X; Zheng L; Shi X; Guo R
    Acta Biomater; 2023 Jul; 164():474-486. PubMed ID: 37040813
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
    Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
    Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phase-Change Material Packaged within Hollow Copper Sulfide Nanoparticles Carrying Doxorubicin and Chlorin e6 for Fluorescence-Guided Trimodal Therapy of Cancer.
    Li Q; Sun L; Hou M; Chen Q; Yang R; Zhang L; Xu Z; Kang Y; Xue P
    ACS Appl Mater Interfaces; 2019 Jan; 11(1):417-429. PubMed ID: 30537815
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Localized Sustained Release of Copper Enhances Antitumor Effects of Disulfiram in Head and Neck Cancer.
    Wang J; Li B; Cooper RC; Huang D; Yang H
    Biomacromolecules; 2024 May; 25(5):2770-2779. PubMed ID: 38687975
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In situ generation of copper(Ⅱ)/diethyldithiocarbamate complex through tannic acid/copper(Ⅱ) network coated hollow mesoporous silica for enhanced cancer chemodynamic therapy.
    Zhu Y; Wang N; Ling J; Yang L; Omer AM; Ouyang XK; Yang G
    J Colloid Interface Sci; 2024 Apr; 660():637-646. PubMed ID: 38266345
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Disulfiram when Combined with Copper Enhances the Therapeutic Effects of Temozolomide for the Treatment of Glioblastoma.
    Lun X; Wells JC; Grinshtein N; King JC; Hao X; Dang NH; Wang X; Aman A; Uehling D; Datti A; Wrana JL; Easaw JC; Luchman A; Weiss S; Cairncross JG; Kaplan DR; Robbins SM; Senger DL
    Clin Cancer Res; 2016 Aug; 22(15):3860-75. PubMed ID: 27006494
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Integrating the drug, disulfiram into the vitamin E-TPGS-modified PEGylated nanostructured lipid carriers to synergize its repurposing for anti-cancer therapy of solid tumors.
    Banerjee P; Geng T; Mahanty A; Li T; Zong L; Wang B
    Int J Pharm; 2019 Feb; 557():374-389. PubMed ID: 30610896
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Programmed near-infrared light-responsive drug delivery system for combined magnetic tumor-targeting magnetic resonance imaging and chemo-phototherapy.
    Feng Q; Zhang Y; Zhang W; Hao Y; Wang Y; Zhang H; Hou L; Zhang Z
    Acta Biomater; 2017 Feb; 49():402-413. PubMed ID: 27890732
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induction of immunogenic cell death in radiation-resistant breast cancer stem cells by repurposing anti-alcoholism drug disulfiram.
    Sun T; Yang W; Toprani SM; Guo W; He L; DeLeo AB; Ferrone S; Zhang G; Wang E; Lin Z; Hu P; Wang X
    Cell Commun Signal; 2020 Mar; 18(1):36. PubMed ID: 32138738
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Repurposing Disulfiram as a Chemo-Therapeutic Sensitizer: Molecular Targets and Mechanisms.
    Sun F; Wang H; Nie J; Hong B
    Anticancer Agents Med Chem; 2022; 22(17):2920-2926. PubMed ID: 35430981
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sphingomyelin-based PEGylation Cu (DDC)
    Liu H; Kong Y; Liu Z; Guo X; Yang B; Yin T; He H; Gou J; Zhang Y; Tang X
    Int J Pharm; 2022 Jun; 621():121788. PubMed ID: 35504431
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antitumor effects of disulfiram/copper complex in the poorly-differentiated nasopharyngeal carcinoma cells via activating ClC-3 chloride channel.
    Xu X; Xu J; Zhao C; Hou X; Li M; Wang L; Chen L; Chen Y; Zhu L; Yang H
    Biomed Pharmacother; 2019 Dec; 120():109529. PubMed ID: 31606620
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Disulfiram chelated with copper promotes apoptosis in human breast cancer cells by impairing the mitochondria functions.
    Yang Y; Zhang K; Wang Y; Li M; Sun X; Liang Z; Wang L; Chen L; Yang H; Zhu L
    Scanning; 2016 Nov; 38(6):825-836. PubMed ID: 27353661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.